Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
Raman Sankar, MD, PhD
Scott Aaronson, MD
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
Meena B. Bansal, MD, FAASLD
Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP
Fernando Bril, MD
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Piotr Ponikowski, MD, PhD, FESC, FHFA
FSGS in Practice: Patient-Centered Decision-Making
Kenneth Lieberman, MD
Howard Trachtman, MD, FASN
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
Impact of Barostim on Heart Failure Hospitalization
Jacob Abraham, MD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Managing Patients With AAV in the Rheumatology Clinic
Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care
Melissa Magwire, RN, MSN, CDE
Matthew Bullington, PharmD
Dawn M. Denicola, FNP-C
Keith Miller, MD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Vallerie V. McLaughlin, MD
Cardiorenal Collaboration: Escape the Treatment Trap
The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective
Naim Alkhouri, MD, FAASLD, DABOM